Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chloe Katz

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
North Carolina Medical Journal|June 4, 2009
Advocacy for refugeesChloe Katz
Scientific Reports|January 10, 2024
Childhood conduct problems and parent-child talk during social and nonsocial play contexts: a naturalistic home-based experimentSydney Sun, Rista C Plate, Callie Jones, et al.
Journal of Personality|October 29, 2021
Are you laughing with me or at me? Psychopathic traits and the ability to distinguish between affiliation and dominance laughter cuesRista C Plate, Sylvia Zhao, Chloe Katz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2025
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)Cameron R Wolfe, Jonathan Cohen, Kathryn Mahoney, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
North Carolina Medical Journal|June 4, 2009
Advocacy for refugeesChloe Katz
Scientific Reports|January 10, 2024
Childhood conduct problems and parent-child talk during social and nonsocial play contexts: a naturalistic home-based experimentSydney Sun, Rista C Plate, Callie Jones, et al.
Journal of Personality|October 29, 2021
Are you laughing with me or at me? Psychopathic traits and the ability to distinguish between affiliation and dominance laughter cuesRista C Plate, Sylvia Zhao, Chloe Katz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2025
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)Cameron R Wolfe, Jonathan Cohen, Kathryn Mahoney, et al.
Pageof 1